Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. MorphoSys AG
  6. News
  7. Summary
    MOR   DE0006632003

MORPHOSYS AG

(MOR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Higher in Tuesday Trading

10/26/2021 | 12:05pm EST


ę MT Newswires 2021
All news about MORPHOSYS AG
12/07European ADRs Move Sharply Higher in Tuesday Trading
MT
12/07MORPHOSYS : Notification of managers`transactions according to article 19 MAR - Form 6-K
PU
12/06European ADRs Climb Higher in Monday Trading
MT
12/06MORPHOSYS AG : Notification and public disclosure of transactions by persons
EQ
12/03European ADRs Move Sharply Lower in Friday Trading
MT
11/30European ADRs Move Lower in Tuesday Trading
MT
11/30MORPHOSYS AG : Preliminary announcement of the publication of quarterly reports and quarte..
EQ
11/29MORPHOSYS AG : Corporate Calendar 2022 - Form 6-K
PU
11/29MORPHOSYS AG : Corporate Calendar 2022
EQ
11/26MORPHOSYS : Notification of managers`transactions according to article 19 MAR - Form 6-K
PU
More news
Analyst Recommendations on MORPHOSYS AG
More recommendations
Financials
Sales 2021 168 M 190 M 190 M
Net income 2021 -67,2 M -76,1 M -76,1 M
Net cash 2021 112 M 127 M 127 M
P/E ratio 2021 -13,0x
Yield 2021 -
Capitalization 1 188 M 1 336 M 1 346 M
EV / Sales 2021 6,41x
EV / Sales 2022 3,73x
Nbr of Employees 771
Free-Float 96,9%
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MORPHOSYS AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 34,81 €
Average target price 77,12 €
Spread / Average Target 122%
EPS Revisions
Managers and Directors
Jean-Paul Kress CEO & Chairman-Management Board
Sung H. Lee Chief Financial Officer
Marc Cluzel Chairman-Supervisory Board
Malte Peters Chief Research & Development Officer
Roland Wandeler Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
MORPHOSYS AG-62.90%1 336
MODERNA, INC.170.27%114 479
LONZA GROUP AG24.16%58 572
IQVIA HOLDINGS INC.50.86%51 638
SEAGEN INC.-16.39%26 777
CELLTRION, INC.-43.31%23 611